Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Allergy and Immunology

Cardiovascular/Pulm

Hyperimmune immunoglobulin for hospitalized patients with COVID-19 (ITAC): A double-blind, placebo-controlled, phase 3, randomized trial

The Lancet | Feb 08, 2022 Cardiovascular/Pulm

Hyperimmune immunoglobulin for hospitalized patients with COVID-19 (ITAC): A double-blind, placebo-controlled, phase 3, randomized trial

The Lancet | Feb 01, 2022 Cardiovascular/Pulm

SARS-CoV-2 antibodies after homologous vs heterologous third vaccine in kidney transplant recipients

JAMA | Dec 24, 2021 Cardiovascular/Pulm

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): A blinded, multicentre, randomised, controlled, phase 2 trial

The Lancet | Dec 23, 2021 Cardiovascular/Pulm

A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia

Journal of Clinical Investigation | Dec 19, 2021 Cardiovascular/Pulm

Association of complement and MAPK activation with SARS-CoV-2–associated myocardial inflammation

JAMA | Dec 18, 2021 Cardiovascular/Pulm

Inhaled corticosteroids alone and in combination with long-acting β2 receptor agonists to treat reduced lung function in preterm-born children: A randomized clinical trial

JAMA | Dec 17, 2021 Cardiovascular/Pulm

Dupilumab in children with uncontrolled moderate-to-severe asthma

New England Journal of Medicine | Dec 13, 2021 Cardiovascular/Pulm

The role of adiposity, diet and inflammation on the discordance between LDL-C and apolipoprotein B

Nutrition, Metabolism & Cardiovascular Diseases | Dec 13, 2021 Cardiovascular/Pulm

Acute myocarditis following COVID-19 mRNA vaccination in adults aged 18 years or older

JAMA | Dec 10, 2021 Cardiovascular/Pulm

« Prev 1 2 3 4 5 … 78 Next »

Hyperimmune immunoglobulin for hospitalized patients with COVID-19 (ITAC): A double-blind, placebo-controlled, phase 3, randomized trial

Hyperimmune immunoglobulin for hospitalized patients with COVID-19 (ITAC): A double-blind, placebo-controlled, phase 3, randomized trial

SARS-CoV-2 antibodies after homologous vs heterologous third vaccine in kidney transplant recipients

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): A blinded, multicentre, randomised, controlled, phase 2 trial

A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia

Association of complement and MAPK activation with SARS-CoV-2–associated myocardial inflammation

Inhaled corticosteroids alone and in combination with long-acting β2 receptor agonists to treat reduced lung function in preterm-born children: A randomized clinical trial

Dupilumab in children with uncontrolled moderate-to-severe asthma

The role of adiposity, diet and inflammation on the discordance between LDL-C and apolipoprotein B

Acute myocarditis following COVID-19 mRNA vaccination in adults aged 18 years or older

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

These Popular Snacks Linked a Decline in Mental Health

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Hyperimmune immunoglobulin for hospitalized patients with COVID-19 (ITAC): A double-blind, placebo-controlled, phase 3, randomized trial

Hyperimmune immunoglobulin for hospitalized patients with COVID-19 (ITAC): A double-blind, placebo-controlled, phase 3, randomized trial

SARS-CoV-2 antibodies after homologous vs heterologous third vaccine in kidney transplant recipients

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): A blinded, multicentre, randomised, controlled, phase 2 trial

A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia

Association of complement and MAPK activation with SARS-CoV-2–associated myocardial inflammation

Inhaled corticosteroids alone and in combination with long-acting β2 receptor agonists to treat reduced lung function in preterm-born children: A randomized clinical trial

Dupilumab in children with uncontrolled moderate-to-severe asthma

The role of adiposity, diet and inflammation on the discordance between LDL-C and apolipoprotein B

Acute myocarditis following COVID-19 mRNA vaccination in adults aged 18 years or older

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

These Popular Snacks Linked a Decline in Mental Health

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Select Specialty

Select Topic